Incidence of dyslipidemia and distribution characteristics of blood lipids in patients with obstructive jaundice
WANG Chuan1, CHEN Pei-xian2, SU Shu-ying1, CHEN Huan-wei3
1. Department of Biliary surgery, Foshan First People's Hospital,Guangdong 528000,China; 2. Department of Breast surgery, Foshan First People's Hospital,Guangdong 528000,China; 3. Department of Liver surgery,Foshan First People's Hospital,Guangdong 528000,China
WANG Chuan, CHEN Pei-xian, SU Shu-ying, CHEN Huan-wei. Incidence of dyslipidemia and distribution characteristics of blood lipids in patients with obstructive jaundice[J]. Chinese Hepatolgy, 2022, 27(8): 912-914.
[1] Björnson E, Packard CJ, Adiels M, et al. Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects. J Intern Med, 2020, 288(4):422-438. [2] Real JT, Ascaso JF. Lipid metabolism and classification of hyperlipaemias. Metabolismo lipídico y clasificación de las hiperlipemias. Clin Investig Arterioscler, 2021, 33 Suppl 1:3-9. [3] Wu SA, Kersten S, Qi L. Lipoprotein lipase and its regulators: an unfolding story. Trends Endocrinol Metab, 2021, 32(1):48-61. [4] Radford-Smith DE, Patel PJ, Irvine KM, et al. Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism. PLoS One, 2022, 17(1):e0261555. [5] Zhang Y, Hu X, Chang J, et al. The liver steatosis severity and lipid characteristics in primary biliary cholangitis. BMC Gastroenterol, 2021, 21(1):395. [6] Gao Z, Wang J, Shen S, et al. The impact of preoperative biliary drainage on postoperative outcomes in patients with malignant obstructive jaundice: a retrospective analysis of 290 consecutive cases at a single medical center. World J Surg Oncol, 2022, 20(1):7. [7] Bao G, Liu H, Ma Y, et al. The clinical efficacy and safety of different biliary drainages in malignant obstructive jaundice treatment. Am J Transl Res, 2021, 13(6):7400-7405. [8] 中国成人血脂异常防治指南修订联合委员会. 中国成人血脂异常防治指南(2016年修订版). 中华健康管理学杂志, 2017, 11(1):7-28. [9] Lu J, Xiong XZ, Cheng Y, et al. One-stage versus two-stage management for concomitant gallbladder stones and common bile duct stones in patients with obstructive jaundice. Am Surg, 2013, 79(11):1142-1148. [10] Zhao Y, Wang S, Liang S, et al. Clinical laboratory characteristics of patients with obstructive jaundice accompanied by dyslipidemia. Clin Biochem, 2021, 94:42-47. [11] 周后钢, 郭伶霞, 王玲等. 阻塞性黄疸患者血脂水平与胆汁酸的相关性分析. 临床检验杂志, 2014, 32(2):109-111. [12] 孟宪华, 吴瑞杰, 蔡迪娅,等.梗阻性黄疸患者血脂的变化及临床意义. 河北医药, 2007, 29(3):210-211. [13] Temi V, Okay E, Güne A, et al. Resveratrol attenuates both small bowel and liver changes in obstructive jaundice. Balkan Med J, 2014, 31(1):95-99. [14] Chennamsetty I, Claudel T, Kostner KM, et al. Farnesoid X receptor represses hepatic human APOA gene expression. J Clin Invest, 2011, 121(9):3724-3734. [15] Yang ZX, Shen W, Sun H. Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease. Hepatol Int, 2010, 4(4):741-748.